NO910331L - Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. - Google Patents

Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Info

Publication number
NO910331L
NO910331L NO91910331A NO910331A NO910331L NO 910331 L NO910331 L NO 910331L NO 91910331 A NO91910331 A NO 91910331A NO 910331 A NO910331 A NO 910331A NO 910331 L NO910331 L NO 910331L
Authority
NO
Norway
Prior art keywords
promoter
recombinant plasmid
plasmid
prl
copper
Prior art date
Application number
NO91910331A
Other languages
English (en)
Norwegian (no)
Other versions
NO910331D0 (no
Inventor
Walter Bodemer
Friedrich Scheiflinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO910331D0 publication Critical patent/NO910331D0/no
Publication of NO910331L publication Critical patent/NO910331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91910331A 1990-01-29 1991-01-29 Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. NO910331L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4002521A DE4002521A1 (de) 1990-01-29 1990-01-29 Rekombinantes plasmid

Publications (2)

Publication Number Publication Date
NO910331D0 NO910331D0 (no) 1991-01-29
NO910331L true NO910331L (no) 1991-07-30

Family

ID=6398977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910331A NO910331L (no) 1990-01-29 1991-01-29 Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.

Country Status (8)

Country Link
EP (1) EP0443335A1 (de)
JP (1) JPH0515374A (de)
CA (1) CA2034564A1 (de)
CS (1) CS18991A2 (de)
DE (1) DE4002521A1 (de)
FI (1) FI910426A (de)
HU (1) HUT61331A (de)
NO (1) NO910331L (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180157B1 (de) * 1999-05-28 2012-11-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vacciniavirus-vektor, dem gleichzeitig ein wachstumsfaktor und die thymidinkinase fehlen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2583429B1 (fr) * 1985-06-18 1989-11-03 Transgene Sa Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
DE3853693D1 (de) * 1987-03-20 1995-06-08 Immuno Ag DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
WO1989008716A1 (en) * 1988-03-18 1989-09-21 The United States Of America, As Represented By Th Novel recombinant vaccinia virus expression vectors and method of selecting same

Also Published As

Publication number Publication date
DE4002521A1 (de) 1991-08-01
NO910331D0 (no) 1991-01-29
CA2034564A1 (en) 1991-07-30
JPH0515374A (ja) 1993-01-26
HUT61331A (en) 1992-12-28
FI910426A0 (fi) 1991-01-29
FI910426A (fi) 1991-07-30
HU910289D0 (en) 1991-08-28
CS18991A2 (en) 1991-09-15
EP0443335A1 (de) 1991-08-28

Similar Documents

Publication Publication Date Title
DK0738327T3 (da) Vært-vektorsystem til anvendelse ved genterapi
ES8604308A1 (es) Un vector para producir un producto genetico por celulas de insectos
AU578011B2 (en) A polycistronic expression vector for vertebrate cells
DE3880468T2 (de) Rekombinante dns-expressionsvektoren.
EP0722461A4 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
NO863000L (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
IE831211L (en) Cloning vectors for expression of exogenous protein
NO834792L (no) Dna-sekvenser, plasmider som inneholder slike sekvenser, samt fremgangsmaater for fremstilling av slike sekvenser og plasmider
IL92264A0 (en) Process for the expression of recombinant genes
NO910331L (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
AU603331B2 (en) Expression vectors containing LAMBDA PL promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
GR3020035T3 (en) Mammalian cell derived autonomously replicating sequence DNA fragments having affinity to DNA binding proteins
ATE259421T1 (de) Dna-virus-vektoren und verfahren zu ihrer herstellung
Hyman Downstep deletion in Aghem
ES546597A0 (es) Un procedimiento para preparar un microorganismo hospedante transformado del genero sacharomyces.
EP0688874A3 (de)
DK577283A (da) Gen kodet for interleukin-2-polypeptid, rekombinant dna baerende dette gen, levende cellelinie indeholdende dette rekombinante dna og fremgangsmaade til fremstilling af interleukin-2 ved anvendelse af denne cellelinie
EP0408301A1 (de) Für eine Signalsequenz kodierende DNA im Vaccinia-Virus
Togashi et al. Insertional mutagenesis in Drosophila II. P element mediated transformation of Drosophila yakuba
ES8704208A1 (es) Un metodo para producir superoxido dismutasa eucariotica enzimaticamente activa o un analogo de la misma